Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group ( EECDRG )
Contact Dermatitis · 2025
DOI: 10.1111/cod.14745 ↗At a glance
Journal article in Contact Dermatitis, 2025. Written by S Mark Wilkinson and 8 co-authors. Institution: Leeds Centre for Dermatology, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Leeds, UK. Major MEDLINE topics: Dermatitis, Allergic Contact, Methacrylates, Cosmetics. Cited 14 times so far (Crossref); 26 references.
Abstract (original language)
Background
There is a current fashion for the use of methacrylate‐containing nail cosmetics that can induce allergic contact dermatitis. European Union (EU) legislation was introduced in 2021 that had the aim of preventing its development.
Objectives
To assess prevalence and exposures causing contact allergy to 2‐hydroxyethyl methacrylate (HEMA) prior to and following implementation of the legislation.
Methods
A retrospective audit was conducted by 7 European centres patch testing to HEMA prior to the legislation and for 2 years afterwards.
Results
A total of 26 297 patients were tested to HEMA in the baseline series between 2016 and 2023. The prevalence of contact allergy to HEMA from all sources amongst females was 2.82% compared to 0.34% amongst males. The prevalence of nail related contact allergy rose from 0.91% in 2016 (2 centres) to: 0.99% in 2017 (3 centres); 1.24% in 2018 (5 centres); 1.23% in 2019 (6 centres); 1.36% in 2020 (7 centres); 1.30% in 2021 (7 centres); 1.52% in 2022 (7 centres) and 1.98% in 2023 (7 centres). Contact allergy to HEMA from exposure to nail cosmetics accounted for 3.4% of all occupational skin disease.
Conclusions
EU legislation appears not to have had the intended impact on controlling allergic contact dermatitis from methacrylates in nail cosmetics. There is an urgent need to revisit Scientific Committee on Consumer Safety (SCCS) opinion to reconsider exposure to methacrylates and cross‐reactions between them. A strategy needs to be developed and implemented to better control the current outbreak.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Leeds Centre for Dermatology, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Leeds, UK.
- University Hospital Antwerp (UZA), University of Antwerp, Antwerp, Belgium.
- Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
- Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.
- Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm) and Department of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Germany.
- Section of Dermatology, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy.
ORCID profiles: S Mark Wilkinson, Olivier Aerts, Tove Agner, Magnus Bruze, Richard Brans, Caterina Foti, Ana Maria Giménez-Arnau, Luca Stingeni, Cecilia Svedman
Cite
APA
Wilkinson, S. M., Aerts, O., Agner, T., Bruze, M., Brans, R., Foti, C., Giménez-Arnau, A. M., Stingeni, L., & Svedman, C. (2025). Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group ( EECDRG ). Contact Dermatitis. https://doi.org/10.1111/cod.14745
Vancouver
Wilkinson SM, Aerts O, Agner T, Bruze M, Brans R, Foti C, et al. Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group ( EECDRG ). Contact Dermatitis. 2025. doi:10.1111/cod.14745
BibTeX
@article{Wilkinson2025,
author = {Wilkinson, S Mark and Aerts, Olivier and Agner, Tove and Bruze, Magnus and Brans, Richard and Foti, Caterina and Giménez-Arnau, Ana Maria and Stingeni, Luca and Svedman, Cecilia},
title = {Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group ( EECDRG )},
journal = {Contact Dermatitis},
year = {2025},
doi = {10.1111/cod.14745}
}
EUVIMED